Patents by Inventor Jim Lee

Jim Lee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TOPICAL TREATMENT OF VITILIGO BY A JAK INHIBITOR
    Publication number: 20260199354
    Abstract: The present disclosure relates to topical treatment of vitiligo using ruxolitinib, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: September 18, 2025
    Publication date: July 16, 2026
    Applicant: Incyte Corporation
    Inventors: Kathleen BUTLER, Jim LEE, Kang SUN, Fiona KUO, Michael HOWELL
  • RUXOLITINIB FORMULATION FOR REDUCTION OF ITCH IN ATOPIC DERMATITIS
    Publication number: 20260191870
    Abstract: This disclosure relates to methods of reducing itch in patients with atopic dermatitis and treating patients with atopic dermatitis by administering a topical 0.75% or 1.5% ruxolitinib cream two times per day.
    Type: Application
    Filed: March 5, 2026
    Publication date: July 9, 2026
    Inventors: Michael Kuligowski, Kang Sun, Michael Howell, May Grace E. Venturanza, Jim Lee
  • Ruxolitinib formulation for reduction of itch in atopic dermatitis
    Patent number: 12589096
    Abstract: This disclosure relates to methods of reducing itch in patients with atopic dermatitis and treating patients with atopic dermatitis by administering a topical 0.75% or 1.5% ruxolitinib cream two times per day.
    Type: Grant
    Filed: July 21, 2025
    Date of Patent: March 31, 2026
    Assignee: Incyte Corporation
    Inventors: Michael Kuligowski, Kang Sun, Michael Howell, May Grace E. Venturanza, Jim Lee
  • VACUUM TANK DOOR LATCHING ASSEMBLY
    Publication number: 20250369268
    Abstract: A door latching mechanism for a tank door. The mechanism includes a rotating shaft with integral tabs. A central tab rotates in response to actuation by a cylinder or other actuator. Outwardly disposed tabs are rotatably connected to hooks which have a specific geometry, allowing them to latch onto shackles on the side of the tank. When latched, the tab's orientation is over center, such that positive force is not needed to maintain the tank in the latched position. The hooks may be concave up or concave down depending upon the geometry of the remainder of the latching mechanism. When unlatched, a single powered hinge may allow the tank to be open, and gravity assists with the disposal of spoils contained therein.
    Type: Application
    Filed: May 22, 2025
    Publication date: December 4, 2025
    Inventor: Jim Lee
  • RUXOLITINIB FORMULATION FOR REDUCTION OF ITCH IN ATOPIC DERMATITIS
    Publication number: 20250345338
    Abstract: This disclosure relates to methods of reducing itch in patients with atopic dermatitis and treating patients with atopic dermatitis by administering a topical 0.75% or 1.5% ruxolitinib cream two times per day.
    Type: Application
    Filed: July 21, 2025
    Publication date: November 13, 2025
    Inventors: Michael Kuligowski, Kang Sun, Michael Howell, May Grace E. Venturanza, Jim Lee
  • Ruxolitinib formulation for reduction of itch in atopic dermatitis
    Patent number: 12396993
    Abstract: This disclosure relates to methods of reducing itch in patients with atopic dermatitis and treating patients with atopic dermatitis by administering a topical 0.75% or 1.5% ruxolitinib cream two times per day.
    Type: Grant
    Filed: October 28, 2022
    Date of Patent: August 26, 2025
    Assignee: Incyte Corporation
    Inventors: Michael Kuligowski, Kang Sun, Michael Howell, May Grace E. Venturanza, Jim Lee
  • Topical treatment of vitiligo by a JAK inhibitor
    Patent number: 12233067
    Abstract: The present disclosure relates to topical treatment of vitiligo using ruxolitinib, or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: December 8, 2022
    Date of Patent: February 25, 2025
    Assignee: Incyte Corporation
    Inventors: Kathleen Butler, Jim Lee, Kang Sun, Fiona Kuo, Michael Howell
  • TOPICAL TREATMENT OF VITILIGO
    Publication number: 20230364095
    Abstract: The present disclosure relates to topical treatment of vitiligo using ruxolitinib, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: September 16, 2021
    Publication date: November 16, 2023
    Applicant: INCYTE CORPORATION
    Inventors: Kathleen BUTLER, Jim LEE, Kang SUN, Fiona KUO, Michael HOWELL
  • TOPICAL TREATMENT OF VITILIGO BY A JAK INHIBITOR
    Publication number: 20230355628
    Abstract: The present disclosure relates to topical treatment of vitiligo using ruxolitinib, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: December 8, 2022
    Publication date: November 9, 2023
    Inventors: Kathleen BUTLER, Jim LEE, Kang SUN, Fiona KUO, Michael HOWELL
  • TOPICAL TREATMENT OF VITILIGO BY A JAK INHIBITOR
    Publication number: 20230293431
    Abstract: The present disclosure relates to topical treatment of vitiligo using ruxolitinib, or a pharmaceutically acceptable salt thereof based on results from long term clinical studies.
    Type: Application
    Filed: February 28, 2023
    Publication date: September 21, 2023
    Inventors: Kathleen BUTLER, Jim Lee, Kang SUN, Fiona KUO, Michael HOWELL
  • RUXOLITINIB FORMULATION FOR REDUCTION OF ITCH IN ATOPIC DERMATITIS
    Publication number: 20230293528
    Abstract: This disclosure relates to methods of reducing itch in patients with atopic dermatitis and treating patients with atopic dermatitis by administering a topical 0.75% or 1.5% ruxolitinib cream two times per day.
    Type: Application
    Filed: October 28, 2022
    Publication date: September 21, 2023
    Inventors: Michael Kuligowski, Kang Sun, Michael Howell, May Grace E. Venturanza, Jim Lee
  • Topical treatment of vitiligo by a JAK inhibitor
    Patent number: 11602536
    Abstract: The present disclosure relates to topical treatment of vitiligo using ruxolitinib, or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: June 10, 2020
    Date of Patent: March 14, 2023
    Assignee: Incyte Corporation
    Inventors: Kathleen Butler, Jim Lee, Kang Sun, Fiona Kuo, Michael Howell
  • Ruxolitinib formulation for reduction of itch in atopic dermatitis
    Patent number: 11590137
    Abstract: This disclosure relates to methods of reducing itch in patients with atopic dermatitis and treating patients with atopic dermatitis by administering a topical 0.75% or 1.5% ruxolitinib cream two times per day.
    Type: Grant
    Filed: March 28, 2022
    Date of Patent: February 28, 2023
    Assignee: Incyte Corporation
    Inventors: Michael Kuligowski, Kang Sun, Michael Howell, May Grace E. Venturanza, Jim Lee
  • Topical treatment of vitiligo by a jak inhibitor
    Patent number: 11590138
    Abstract: The present disclosure relates to topical treatment of vitiligo using ruxolitinib, or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: July 8, 2022
    Date of Patent: February 28, 2023
    Assignee: Incyte Corporation
    Inventors: Kathleen Butler, Jim Lee, Kang Sun, Fiona Kuo, Michael Howell
  • TOPICAL TREATMENT OF VITILIGO BY A JAK INHIBITOR
    Publication number: 20220409622
    Abstract: The present disclosure relates to topical treatment of vitiligo using ruxolitinib, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: July 8, 2022
    Publication date: December 29, 2022
    Inventors: Kathleen BUTLER, Jim LEE, Kang SUN, Fiona KUO, Michael HOWELL
  • Ruxolitinib formulation for reduction of itch in atopic dermatitis
    Patent number: 11510923
    Abstract: This disclosure relates to methods of reducing itch in patients with atopic dermatitis and treating patients with atopic dermatitis by administering a topical 0.75% or 1.5% ruxolitinib cream two times per day.
    Type: Grant
    Filed: September 4, 2020
    Date of Patent: November 29, 2022
    Assignee: Incyte Corporation
    Inventors: Michael Kuligowski, Kang Sun, Michael Howell, May Grace E. Venturanza, Jim Lee
  • RUXOLITINIB FORMULATION FOR REDUCTION OF ITCH IN ATOPIC DERMATITIS
    Publication number: 20220280518
    Abstract: This disclosure relates to methods of reducing itch in patients with atopic dermatitis and treating patients with atopic dermatitis by administering a topical 0.75% or 1.5% ruxolitinib cream two times per day.
    Type: Application
    Filed: March 28, 2022
    Publication date: September 8, 2022
    Inventors: Michael Kuligowski, Kang Sun, Michael Howell, May Grace E. Venturanza, Jim Lee
  • RUXOLITINIB FORMULATION FOR REDUCTION OF ITCH IN ATOPIC DERMATITIS
    Publication number: 20210069195
    Abstract: This disclosure relates to methods of reducing itch in patients with atopic dermatitis and treating patients with atopic dermatitis by administering a topical 0.75% or 1.5% ruxolitinib cream two times per day.
    Type: Application
    Filed: September 4, 2020
    Publication date: March 11, 2021
    Inventors: Michael Kuligowski, Kang Sun, Michael Howell, May Grace E. Venturanza, Jim Lee
  • TOPICAL TREATMENT OF VITILIGO BY A JAK INHIBITOR
    Publication number: 20210030672
    Abstract: The present disclosure relates to topical treatment of vitiligo using ruxolitinib, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: September 16, 2020
    Publication date: February 4, 2021
    Inventors: Kathleen BUTLER, Jim LEE, Kang SUN, Fiona KUO, Michael HOWELL
  • TOPICAL TREATMENT OF VITILIGO BY A JAK INHIBITOR
    Publication number: 20200405627
    Abstract: The present disclosure relates to topical treatment of vitiligo using ruxolitinib, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: June 10, 2020
    Publication date: December 31, 2020
    Inventors: Kathleen BUTLER, Jim LEE, Kang SUN, Fiona KUO, Michael HOWELL